# EarlyBird

> EarlyBird is a VC fund in London backing Financial Services and FinTech. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 9
- Last investment: Mar 2025
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/earlybird-by-owner/
- Website: http://www.earlybird.fm

EarlyBird is a postal snacking service that delivers healthy snacks to its users’ doorstep. It provides its users with TasteBox, 5 healthy snacks and 2 unique teas, to help them through the working week. Its TasteBox also contains music and art from up and coming artists. EarlyBird was launched in 2014 and is based in London, England.

## Contacts

5 contacts available for EarlyBird. Shizune tracks 5 team members at EarlyBird. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/earlybird-3?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $6M–$12M |
| Series A | $3.3M–$26M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Financial Services | 4 | 44% |
| FinTech | 3 | 33% |
| Software | 2 | 22% |
| Health Care | 2 | 22% |
| Biotechnology | 2 | 22% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 22% |
| Series A | 2 | 22% |
| Series B | 2 | 22% |
| Funding Round | 2 | 22% |
| Pre-Seed | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 4 | 44% |
| Ireland | 1 | 11% |
| Romania | 1 | 11% |
| United Kingdom | 1 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Helen Hopper | New Product Developer and Nutrition | 0 | https://shizune.co/investors/profile/helen-hopper |
| Jamie Trinder | Customer Service and Mobile Developer | 0 | https://shizune.co/investors/profile/jamie-trinder |
| Pete Hazell | Creative Director | 0 | https://shizune.co/investors/profile/pete-hazell |
| Sarah Alcock | Social Media and Customer Comms | 0 | https://shizune.co/investors/profile/sarah-alcock |
| Thomas Atherton | Operations Manager | 0 | https://shizune.co/investors/profile/thomas-atherton |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Perfuze | Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway. | $23.9M |  | Mar 13, 2025 |  |
| Sikoia | Sikoia is a London-based Fintech that helps financial services providers automate key parts of their customer verification processes. Designed to streamline the customer verification process, Sikoia offers centralised access to organised customer data, alongside providing automated insights that simplify the onboarding experience. Its solutions arebuilt for seamless integration into existing systems via API, or for direct use through its straightforward, ready-to-use Customer Evaluation Dashboard. Sikoia serves Fintechs and larger established institutions in more than three countries, is regulated by the Financial Conduct Authority (FCA) as an Account Information Service Provider (AISP) and Credit Reference Provider, and is backed by leading institutional investors. | $6M | Seed | Feb 16, 2023 |  |
| Goodlegal | Goodlegal serves as a one-stop shop for all legal requirements. It focuses on compliance, it should be able to compete with in-house lawyers, who handle an organization's internal legal matters, and law firms on both ends of the legal spectrum. | $1.2M | Pre-Seed | Nov 22, 2022 |  |
| Noscendo | Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections. |  |  | May 16, 2022 |  |
| Noscendo | Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections. |  | Series B | May 16, 2022 |  |
| finmid | finmid is the embedded lending infrastructure powering platform growth. finmid enables platforms to launch tailored financing products for their business customers at scale across 30 European markets via single integration. Across industries and business models, finmid drives revenue, improves retention, and fuels core business growth. finmid istrusted by Europe’s most ambitious platforms, including Wolt, Delivery Hero, Bolt, Just Eat Takeaway, Guesty, and FREENOW. Learn more at finmid.com. | $12M | Seed | Feb 11, 2022 |  |
| Perfuze | Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway. | $25.7M | Series A | Feb 07, 2022 |  |
| Fraugster | Fraugster is a German-Israeli anti-fraud company that uses artificial intelligence to eliminate fraud and increase customers’ profits.Fraugster's journey began in 2014 with the vision to design and build an anti-fraud technology that can help create a fraud free world - one where no one has to care about managing risk again. After years ofworking in the payments industry, the founders experienced first-hand the challenges of fraud for e-commerce merchants. The founders discovered that all existing anti-fraud solutions were built on outdated technologies and therefore not good enough to deal with sophisticated cyber criminals. Existing rule-based systems as well as classical machine learning solutions are expensive and can't adapt to new fraud patterns in real-time, hence inaccurate. | $14M | Series B | Nov 07, 2018 |  |
| Cashboard | CASHBOARD is Europe’s first and only curated marketplace for retail investment covering all asset classes and one of the fastest growing online wealth management FinTechs in Germany.While others just sell one product CASHBOARD offers an individually tailored portfolio with access to the complete market range of traditional (Daily Deposits,Stocks, Funds, ETF) AND the rapidly growing segment of alternative investment products (P2P Lending, SME Lending, Real Estate Crowdfunding, Precious Metals, Sustainable Investing etc.).Leading European FinTechs and notable banks already partner with CASHBOARD currently offering more than 6,500 investment products on the open technology platform. Retail clients benefit from the one-stop-shop solution which enables them to manage all their assets in a single account. For them the platform is completely free of charge except for a success-related performance fee.CASHBOARD is recognized as one of the 9 top wealth tech companies in Europe (2017) and one of the market-leading companies in Germany (Aixigo/Springer 2016). The team has received several notable awards including Europe’s highest endowed startup prize – the SevenVentures Pitch Day from NOAH London worth €4m TV media and is backed by top-tier international VC’s including 500 Startups, Earlybird, Digital Space Ventures, Redalpine, ProSiebenSat.1 and more. | $3.3M | Series A | Nov 23, 2016 |  |

9 of 9 investments shown.

## Co-investors
- [SV Health Investors](https://shizune.co/investors/profile/sv-life-sciences) — VC Fund, 3 deals together
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 2 deals together
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 2 deals together
- [Revent](https://shizune.co/investors/profile/revent-capital) — VC Fund, 2 deals together
- [Seedcamp](https://shizune.co/investors/profile/seedcamp) — VC Fund, 2 deals together
- [Seroba Life Sciences](https://shizune.co/investors/profile/seroba-life-sciences) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Ireland](https://shizune.co/investors/health-care-vc-funds-ireland)
- [Biotech Investors in Ireland](https://shizune.co/investors/biotech-investors-ireland)
- [Biotech VC Funds in Ireland](https://shizune.co/investors/biotech-vc-funds-ireland)
- [Health Care Investors in Ireland](https://shizune.co/investors/health-care-investors-ireland)
- [All VC Funds in Romania](https://shizune.co/investors/vc-funds-romania)
- [Medical VC Funds in Ireland](https://shizune.co/investors/medical-vc-funds-ireland)

## FAQ

### What does EarlyBird invest in?

EarlyBird invests primarily in Financial Services, FinTech and Software startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is EarlyBird's check size?

EarlyBird typically joins rounds of $6M–$12M at Seed and $3.3M–$26M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds EarlyBird participates in.

### How do I contact EarlyBird?

Public channels for EarlyBird include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at EarlyBird?

The team at EarlyBird includes Helen Hopper (New Product Developer and Nutrition), Jamie Trinder (Customer Service and Mobile Developer) and Pete Hazell (Creative Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co